» Articles » PMID: 35741712

Genetic Expression Between Ageing and Exercise: Secreted Protein Acidic and Rich in Cysteine As a Potential "Exercise Substitute" Antiageing Therapy

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2022 Jun 24
PMID 35741712
Authors
Affiliations
Soon will be listed here.
Abstract

Ageing is the effect of time on biological entities. It represents a risk factor for a variety of diseases and health disorders; thus, therapeutic options are required to tackle ageing issues. Modern geriatric medicine prescribes exercise to counteract ageing effects. This work presents secreted protein acidic and rich in cysteine (SPARC) as a potential antiageing therapy. Indeed, SPARC declines with ageing, exercise induces SPARC, and SPARC overexpression in mice mimics exercise. Thus, we hypothesize that SPARC is an exercise-induced factor that is beyond-at least part of-the antiageing effects induced by exercise. This could become a potential antiageing therapy for the elderly that counteracts ageing by mimicking the effects of exercise without needing to perform exercise. This is of particular importance because ageing usually reduces mobility and age-related diseases can reduce the ability to perform the required physical activity. On the other hand, the possibilities of mimicking exercise benefits via SPARC are not limited to ageing, and can be applied in various contexts in which exercise cannot be performed because of physical disabilities, health disorders, or limited mobility.

Citing Articles

Time-resolved map of serum metabolome profiling in D-galactose-induced aging rats with exercise intervention.

Li X, Wei C, Jin Y, Zhang J, Zhong P, Zhang D iScience. 2024; 27(2):108999.

PMID: 38362265 PMC: 10867647. DOI: 10.1016/j.isci.2024.108999.


Secreted Protein Acidic and Rich in Cysteine (SPARC) to Manage Coronavirus Disease-2019 (COVID-19) Pandemic and the Post-COVID-19 Health Crisis.

Ghanemi A, Yoshioka M, St-Amand J Medicines (Basel). 2023; 10(5).

PMID: 37233608 PMC: 10220988. DOI: 10.3390/medicines10050032.


Secreted Protein Acidic and Rich in Cysteine ()-Mediated Exercise Effects: Illustrative Molecular Pathways against Various Diseases.

Ghanemi A, Yoshioka M, St-Amand J Diseases. 2023; 11(1).

PMID: 36810547 PMC: 9944512. DOI: 10.3390/diseases11010033.


Mapping Genetics and Epigenetics to Explore the Pathways beyond the Correlated Ageing Phenotype.

Ghanemi A, Yoshioka M, St-Amand J Genes (Basel). 2022; 13(11).

PMID: 36421843 PMC: 9690414. DOI: 10.3390/genes13112169.


In Vitro Mimicking of Obesity-Induced Biochemical Environment to Study Obesity Impacts on Cells and Tissues.

Ghanemi A, Yoshioka M, St-Amand J Diseases. 2022; 10(4).

PMID: 36278576 PMC: 9590073. DOI: 10.3390/diseases10040076.


References
1.
Mansergh F, Wells T, Elford C, Evans S, Perry M, Evans M . Osteopenia in Sparc (osteonectin)-deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression. Physiol Genomics. 2007; 32(1):64-73. PMC: 2323447. DOI: 10.1152/physiolgenomics.00151.2007. View

2.
Norose K, Clark J, Syed N, Basu A, Heber-Katz E, Sage E . SPARC deficiency leads to early-onset cataractogenesis. Invest Ophthalmol Vis Sci. 1998; 39(13):2674-80. View

3.
Ghanemi A, Yoshioka M, St-Amand J . Ageing and Obesity Shared Patterns: From Molecular Pathogenesis to Epigenetics. Diseases. 2021; 9(4). PMC: 8700721. DOI: 10.3390/diseases9040087. View

4.
Ghanemi A, Yoshioka M, St-Amand J . Exercise, Diet and Sleeping as Regenerative Medicine Adjuvants: Obesity and Ageing as Illustrations. Medicines (Basel). 2022; 9(1). PMC: 8778846. DOI: 10.3390/medicines9010007. View

5.
Ghanemi A, Yoshioka M, St-Amand J . Impact of Adiposity and Fat Distribution, Rather Than Obesity, on Antibodies as an Illustration of Weight-Loss-Independent Exercise Benefits. Medicines (Basel). 2021; 8(10). PMC: 8537631. DOI: 10.3390/medicines8100057. View